Although no additional data is available to substantiate these findings and/or provide clarifying mechanistic information, CLL-B cell-associated Fibromodulin has the potential to act as a potent promoter of the expansion of autologous tumour-specific T cells. The gene discussed is FMOD; the disease is B-cell chronic lymphocytic leukemia.